| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

Department of Heart and Hypertension Research, Research Institute of the Cleveland Clinic Foundation Cleveland, Ohio 44195-5071
Address all correspondence and requests for reprints to: Ahsan Husain, Ph.D., Department of Heart and Hypertension Research, Research Institute of the Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195-5071.
Abstract
Ovarian angiotensin I (Ang I)-converting enzyme (ACE), estimated by the specific binding of the ACE inhibitor [125I]iodo-MK-351A, is localized on multiple ovarian structures, including follicular granulosa cells, corpora lutea, germinal epithelium, and ovarian blood vessels, but total ovarian ACE does not display a cyclic pattern of variation during the rat estrous cycle. We have previously shown that ACE is localized on the granulosa cell layer of a subpopulation of rat ovarian follicles. Our present study shows that ovarian granulosa cells contain high affinity [binding site affinity (Kd), -90 pM] and low capacity [binding site density (BmM), -12 fmol/2.5 x 105 cells] [128I]iodo-MK-351A-binding sites and convert [125I]iodo- Ang I to [125I]iodo-Ang II (>85% of this conversion was inhibited by the ACE inhibitor captopril). Throughout the rat estrous cycle, 94-100% of developing follicles and 89-96% of atretic follicles contained high levels of ACE; however, ACE was either not observed or its levels were very low in preovulatory follicles. These findings indicate the presence of high levels of biologically active ACE on the surface of granulosa cells and suggest a potential role for follicular ACE in early stages of follicular maturation and atresia.
Although ACE is known to process a variety of peptides found within the ovary, and these peptides may have opposing effects on follicular maturation, we attempted to define the cumulative effect of ACE inhibition on follicular maturation. Short and long term (6- and 14-day) infusions of captopril (6-day, 30.5 ± 3.5 ova; 14-day, 28.5 ± 7.5 ova) in immature rats, in which ovulation was induced by sequential treatments with PMSG and hCG, did not significantly affect ovulation compared with that in vehicle-infused control rats (6-day, 22.4 ± 2.4 ova; 14-day, 20.8 ± 3.1 ova), suggesting that ACE inhibition does not modify the follicular selection process in a way that affects ovulation. This may explain the lack of any reports of adverse effects of clinically used ACE inhibitors on ovulation. (Endocrinology 126: 2927–2935, 1990)
Footnotes
* This work was supported by a grant from the Reinberger Foundation and NIH Grant HD-23925.
Recipient of a fellowship from the American Heart Association, Northeast Ohio Affiliate.
Received January 16, 1990.
This article has been cited by other articles:
![]() |
V. M. Pereira, F. M. Reis, R. A. S. Santos, G. D. Cassali, S. H. S. Santos, K. Honorato-Sampaio, and A. M. dos Reis Gonadotropin Stimulation Increases the Expression of Angiotensin-(1--7) and Mas Receptor in the Rat Ovary Reproductive Sciences, December 1, 2009; 16(12): 1165 - 1174. [Abstract] [PDF] |
||||
![]() |
J. R. Pepperell, G. Nemeth, Y. Yamada, F. Naftolin, and M. Merino Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E221 - E233. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Bokal, H. M. Vrtovec, I. V. Klun, and I. Verdenik Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome Hum. Reprod., June 1, 2005; 20(6): 1562 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. R. Costa, C. R. Fagundes-Moura, V. M. Pereira, L. F. Silva, M. A. R. Vieira, R. A. S. Santos, and A. M. Dos Reis Angiotensin-(1-7): A Novel Peptide in the Ovary Endocrinology, May 1, 2003; 144(5): 1942 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.H. Schauser, A.H. Nielsen, H. Winther, V. Dantzer, and K. Poulsen Localization of the Renin-Angiotensin System in the Bovine Ovary: Cyclic Variation of the Angiotensin II Receptor Expression Biol Reprod, December 1, 2001; 65(6): 1672 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Antczak and J. Van Blerkom The vascular character of ovarian follicular granulosa cells: phenotypic and functional evidence for an endothelial-like cell population Hum. Reprod., November 1, 2000; 15(11): 2306 - 2318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gutkowska, M. Jankowski, M. Ram Sairam, N. Fujio, A. M. Reis, S. Mukaddam-Daher, and J. Tremblay Hormonal Regulation of Natriuretic Peptide System during Induced Ovarian Follicular Development in the Rat Biol Reprod, July 1, 1999; 61(1): 162 - 170. [Abstract] [Full Text] |
||||
![]() |
M. Bramucci, A. Miano, A. Gobbetti, M. Zerani, L. Quassinti, E. Maccari, O. Murri, and D. Amici Different modulation of steroidogenesis and prostaglandin production in frog ovary in vitro by ACE and ANG II Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R2089 - R2096. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |